Algo version: 0.98b
Joinn Laboratories is listed at the HKSE Exchange
Joinn Laboratories [6127.HK]
HKSE Sector: Healthcare Industry:Diagnostics & Research

Is Joinn Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Joinn Laboratories pays dividends. Last time was Wednesday 31st of July 2024 where the investors holding the stock on Friday 28th of June 2024 were paid HKD0.1933 per share. Over the last 4 times between 2021 and 2024, Joinn Laboratories has paid HKD1.9671 with an average of HKD0.49 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Joinn Laboratories 10 years ago, but if you had invested on Friday 26th of February 2021 when the price was HKD50.29, you would have made a loss of HKD-43.64 per share or -86.78%

Yes, the average daily trading liquidity for Joinn Laboratories is HKD830 121 thousand. You should therefore be able to get in and out of your positions relatively fast.

Joinn Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 11.91, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Joinn Laboratories to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.